Novo A/S is fully owned by the Novo Nordisk Foundation. It oversees, invests and manages the assets of the Novo Nordisk Foundation. Besides being the controlling shareholder in the Novo Group companies, including Novo Nordisk A/S and Novozymes A/S, Novo A/S provides seed and venture capital to development stage companies and takes significant ownership positions in well-established companies within life science, as well as manages a broad portfolio of financial assets.

TypeInvestor
HQHellerup, DK
Founded1999
Websitenovoholdings.dk
Cybersecurity ratingBMore
Novo A/S was founded in 1999 and is headquartered in Hellerup, DK

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Novo A/S

Kasim Kutay

Kasim Kutay

CEO

Novo A/S Office Locations

Novo A/S has offices in Hellerup, Boston, San Francisco and London
Hellerup, DK (HQ)
19 Tuborg Havnevej
London, GB
Marfin Popular Bank, 12 Hay Hill, Mayfair
Boston, MA, US
John Hancock Tower, 200 Clarendon St floor 45
San Francisco, CA, US
501 2nd St #300, San Francisco
Show all (4)

Novo A/S Online and Social Media Presence

Embed Graph

Novo A/S Blogs

Novo Holdings co-leads Hemab’s US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders

The post Novo Holdings co-leads Hemab’s US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders appeared first on Novo Holdings.

Novo Holdings A/S invests in US healthcare IT company Availity

The post Novo Holdings A/S invests in US healthcare IT company Availity appeared first on Novo Holdings.

Novo Holdings’ portfolio company Cyteir Therapeutics goes public

The post Novo Holdings’ portfolio company Cyteir Therapeutics goes public appeared first on Novo Holdings.

Novo Holdings co-leads $245 million financing of British medical technology pioneer Quanta

The post Novo Holdings co-leads $245 million financing of British medical technology pioneer Quanta appeared first on Novo Holdings.

Novo Holdings to acquire BBI Group

The post Novo Holdings to acquire BBI Group appeared first on Novo Holdings.

Novo Seeds Launches Tribune Therapeutics to Develop Novel Medicines Targeting a Wide Range of Fibrotic Diseases

The post Novo Seeds Launches Tribune Therapeutics to Develop Novel Medicines Targeting a Wide Range of Fibrotic Diseases appeared first on Novo Holdings.
Show more

Novo A/S Frequently Asked Questions

  • When was Novo A/S founded?

    Novo A/S was founded in 1999.

  • Who are Novo A/S key executives?

    Novo A/S's key executives are Kasim Kutay.

  • Where is Novo A/S headquarters?

    Novo A/S headquarters is located at 19 Tuborg Havnevej, Hellerup.

  • Where are Novo A/S offices?

    Novo A/S has offices in Hellerup, Boston, San Francisco and London.

  • How many offices does Novo A/S have?

    Novo A/S has 4 offices.